7 Tips For Finding a Clinical Trial for Your Rare Disease
The world of Clinical Trials can be a mystery for many. The process can be cumbersome, and as we know, there are not always clinical trials going on in the wide range of rare diseases, making it sometimes frustrating and an emotional rollercoaster. Here are some pointers to get familiar with that will help you along your way toward finding the right clinical trial for you.
The most comprehensive source of clinical studies is clinicaltrials.gov
All new studies for therapies seeking FDA approval are listed on the FDA website clinicaltrials.gov, and can be searched by the disease.
Note the phase of the study
These are the stages of study for a new medication which is part of the approval process with the FDA.
Phase I studies are designed to study the safety of the medication. This may have only a few participants and may be with healthy volunteers.
Phase 2 studies are designed to see if the medication is effective. This is also a “proof” study, and the medication is given to people with the disease or condition.
Phase 3 studies have more participants to make sure the Phase 2 results are similar in a larger group of people with the condition or disease. It is usually the final phase before applying for approval from the FDA.
Phase IV studies, after the medication is approved by the FDA, continue to be studied over a longer period of time
3. Look at the type of study
Biomarker studies are studies looking at risk factors, signs of disease, or severity of disease.
Natural history studies: these studies show how the symptoms of a disease can change or progress over time.
Interventional studies: these are studies of medications, devices, or non-medical therapies that can be used to treat a condition or symptoms of that condition
4. Check the inclusion/exclusion criteria which specify the requirements to participate in the study
The inclusion criteria are the qualities a person must have to participate such as your diagnosis, how long you’ve been diagnosed, your age, symptoms, what medication you’re taking, and findings from your lab or blood tests (such as platelet or white blood cell levels, kidney and liver findings, genes or antibodies)
Exclusion criteria if you have these factors, you probably will not be able to participate in the study. This can include:
Medications you might be taking, or a recent change in medication
Other conditions you may have (such as heart disease, liver disease, etc.)
Procedures or surgeries you may have had, like plasmapheresis or thymectomy
5. Ask about travel assistance
If there is no study center location in your area, often the sponsor may reimburse you or pay for travel expenses or overnight stays in a hotel nearby. This is something you can ask the study team when you speak to them, or there may be an email address to contact if you are interested in learning more about the study.
6. You can get free access to a potential new treatment for your disease
Although there is no guarantee that the medication in development will be effective for you, if you do participate in a study and the medication seems to be working well for you, you may be able to continue receiving the medication free of cost for an extended period of time, until it’s approved by the FDA for use. (Note that different studies can have different extended use provisions).
Deciding whether to participate is not always an easy decision, but doing so can offer the potential to help not just you, but other individuals with the same condition in the future. Not every clinical trial results in an approved medication and many medications fail to meet their goals and are never approved.
7. Use Know Rare, which makes it easier to find a clinical study and talk to a researcher
The Know Rare Study Finder provides an easy search tool for all the clinical studies listed on clinicaltrials.gov. By filling out a short survey just once, you can be matched to a clinical study for a potential treatment for your disease or condition.
If you choose to apply to a study offering virtual pre-screening visits, you can schedule a live virtual ‘visit’ with a member of the study’s research team who can review all you need to know about the study and see if you are eligible to participate in it.
If you don’t meet the requirements for one study, it matches you to any others that are listed for your disease, and it is updated constantly, so even if there’s no study for you today, there may be one for you tomorrow.
To find a study for your disease or condition, contact us here.
Latest From Know Rare
From prenatal uncertainty and postpartum anxiety to therapy, grief, and hope, a mother shares her experience raising a child with a rare disease, navigating the healthcare system, finding community, and learning to embrace a different—but deeply meaningful—path as a parent.
A Danon disease study, led by researcher Dr. Barry Greenberg and published in the New England Journal of Medicine, wins an award! The study focuses on gene therapy as a potential treatment option for Danon disease. The study showed early signs that gene therapy may help the hearts of people with Danon disease.
A poster, presented at the European Hematology Association meeting in June, described a study that looked at tiredness (fatigue) in adults with immune thrombocytopenia (ITP). Researchers wanted to see if fatigue was related to bleeding or other health test results.
Lucky Shanmugan was recently featured in Porter Ranch Living, his local magazine, for Father’s Day: in his interview, Lucky talks about Osteogenesis Imperfecta, a rare genetic or heritable disorder of the connective tissue, and the incredible journey towards his official diagnosis.
Here are 9 things Chris Anselmo wishes someone had told him after his rare disease diagnosis.
A family’s hardships and resilience in finding answers and getting a diagnosis for their child, after numerous tests, brain biopsies, and hospitalizations. And the relief but also grief in finally putting a name to the rare disease that affects their child: BCL11B-related disorder.
The Danon Foundation boldly empowers people living with Danon disease, providing trusted information, resources and support to help navigate life, from diagnosis to treatment.
For many families, caregiving for a child with a rare or medically complex condition is a full-time job. The problem is, it’s a job with no training, no time off, and no clear job description. If you’re looking for the light at the end of the tunnel, you don’t have to search alone. Check out some of Paige’s favorite resources.
For most of celiacs, despite months on a strict GF diet, energy stays low and blood work reveals nutrient deficiencies. The lesson? A "gluten-free" label isn't a health guarantee—just a guarantee you'll pay more.
If you’ve been told you have seronegative NMOSD, there’s nearly 50/50 chance you have a different antibody causing your symptoms –MOG antibody.
Therapy Near Me is a nationwide mental health service based in Australia, providing easy access to psychologists, counsellors, behaviour support practitioners and social workers.
At the annual Kidney Week of the American Society of Nephrologists (ASN), the world’s largest kidney healthcare professional organization, new advances in research were highlighted. Over $35 million has been invested in research with the ASN, and there are many treatments in development for IgA Nephropathy (IgAN), with researchers actively investigating more than 20 different drugs.
When I was diagnosed with celiac disease, I thought avoiding bread and pasta would be enough. I quickly learned that living truly gluten-free is far more complex, and I'm sharing my experience to help newly diagnosed individuals understand what lies ahead.
Retinopathy is an eye problem that many people with Danon disease have. It can cause dark spots in the outer part of the eye, blurry or worse vision, and unusual test results on an eye exam. Sometimes these eye changes show up before heart problems, so an eye check can help find the disease early.
A heartfelt story about a mother who found purpose and strength among the tragedy of losing a child diagnosed with an ultra rare genetic disorder.
Kaya Girl Legacy, Inc. is a Florida-based nonprofit founded in memory of Kaya Humbert, a beautiful baby girl born with Sphingosine Phosphate Lyase Insufficiency Syndrome (SPLIS), one of 46 known cases worldwide. The foundation is dedicated to empowering families with knowledge about their genetic health and advocating for early access to genetic testing and rare disease awareness.
A prose poem by Jim Kuhn, a rare warrior living with Sarcoidosis, a rare inflammatory disease.
Rare Mom Laura shares how her family’s prep for Halloween turned into a burst of familial love and creativity, as they all worked together in designing and building a costume for Alden, her medically complex son.
Instead of starting with a newly discovered drug compound, PCOR is a type of research that starts by turning to patients and caregivers and asking, What matters most to you? What questions do we want answered? What symptoms do we wish were better managed? What keeps us up at night?
Four years ago, Michael Grivas’ life suddenly changed when he learned that he had Brugada Syndrome, a genetic disorder in which the electrical activity of the heart is abnormal due to channelopathy. Learn more about his story.
Fatigue is a very common and often debilitating symptom of IgAN. It is linked to disease progression and reduced kidney function, but other factors like inflammation, anemia, and mental health also play a role. In a 2025 study, the majority of patients with IgAN reported fatigue, and patients with more severe proteinuria and lower kidney filtration rates (eGFR) experienced worse fatigue.
Why is it so hard to accept help? Humans often associate help with weakness and loss of independence and control. However, if we reframe our thoughts, accepting help can be viewed as a form of empowerment: showing vulnerability and trusting someone to help us requires great strength.
There is so much mental load with having a rare disease. Rare Human Lindsay shares there are things she does not care about anymore, as she manages rare disease symptoms, specialists, and clinical trials.
Rare Human Lindsay shares her "silver linings." It's not 'what doesn't kill you makes you stronger,' instead it's what doesn't kill you makes you braver. She shares that she has found deeper connections with others, improved her ability to ask for and accept help, and not been as afraid of the word "no."
Journalist and rare disease advocate Lindsay Guentzel breaks down why clinical trials are a lifeline for the rare disease community. With only 5% of known rare diseases having an FDA-approved therapy, trials often represent the only path toward treatment, progress, and hope.
Lindsay was diagnosed with dermatomyositis a couple of years ago. Since then, she has undergone more than 350 doctor appointments, 250+ hours of infusions, 10+ ER visits, while juggling insurance approvals, rides, and her pain and fatigue.
Rare Human Lindsay is in the midst of her first clinical trial for dermatomyositis, a rare inflammatory disease that primarily affects the skin and muscles. So far, she has learned so much about the process and is eager to share some of her insights with the rare disease community.
Nina is the co-founder and president of Know Rare
Nina’s experience goes across therapeutic categories from rare disease like pulmonary arterial hypertension (PAH), autoimmune disease and cancer, and her expertise ranges from market research and strategy to patient and digital marketing.
Additionally, she has been a founder and angel investor of a biotech start-up, helped brand an oncology patient organization, Aim at Melanoma, and worked on patient education for Genentech’s leading HER2 therapy, Herceptin.
Nina is also a mother, grandmother, artist, and author of The Gallery of Beauties, a novel set in the Venice in the early 17th century.